High grade malignant gliomas are the most frequent type of lethal adult brain tumor, and there is no current effective treatment. Amiloride is an FDA-approved diuretic that inhibits the proliferation of malignant glioma cells and, at high concentrations, selectively kills human glioma cells. Intracranial infusion of amiloride significantly decreased the rate of tumor growth of intracerebral human glioma xenografts in athymic rats, and killed glioma cells in poorly vascularized tumor regions. A primary objective of this application is to identify the cellular mechanisms by which amiloride selectively kills malignant glioma cells. Recently published data indicate that glioma cytotoxicity could arise from amiloride's dual inhibition of the sodium calcium exchanger (NCX) and of the type 1 sodium proton exchanger (NHE1). Nonspecific cellular toxicities of the more potent, lipophilic amiloride derivatives correspond with their intracellular permeation. We hypothesize that conjugating amino acids or peptides to the C (5) position and to the C(2) guanidine moiety of amiloride can generate novel hydrophilic amiloride derivatives, and limit drug activities to cell surface transporters. C (2) amiloride glycine conjugate inhibits NCX>NHE1, and is at least 50-fold more potent than amiloride in selectively killing glioma cells. C (5) amiloride glycine conjugate inhibits NHE1""""""""NCX, and when coupled to an opioid-like pentapeptide created an inactive prodrug. This prodrug liberates bioactive C (5)-Am-Gly when incubated with enkephalinase. In a similar fashion, we envision that glioma-specific peptidases, such as metalloproteinases, could regionally activate amiloride-peptide prodrugs. The investigator proposes to further analyze the cellular mechanisms by which inhibitors of NCX and NHE1 selectively kill glioma cells. Syntheses of novel amiloride amino acid and peptide conjugates will be guided by these mechanistic studies, by their inhibitory activities on NCX and NHE1, and by screening their anti-cancer properties in a panel of human glioma cell lines and primary astrocytes. The most selective and efficacious of these novel amiloride derivatives will be infused intracranial into human glioma xenografts implanted intracerebrally into athymic rats. The pharmacokinetics, neurotoxicities, and neuropathology of these compounds also will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS040489-05
Application #
7035267
Study Section
Drug Discovery and Molecular Pharmacology Study Section (DMP)
Program Officer
Fountain, Jane W
Project Start
2001-06-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
5
Fiscal Year
2006
Total Cost
$337,846
Indirect Cost
Name
University of California Davis
Department
Neurology
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Pasupuleti, Nagarekha; Grodzki, Ana Cristina; Gorin, Fredric (2015) Mis-trafficking of endosomal urokinase proteins triggers drug-induced glioma nonapoptotic cell death. Mol Pharmacol 87:683-96
Andreozzi, Erica; Wang, Peter; Valenzuela, Anthony et al. (2013) Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging. Bioconjug Chem 24:1455-67
Pasupuleti, Nagarekha; Leon, Leonardo; Carraway 3rd, Kermit L et al. (2013) 5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor. J Pharmacol Exp Ther 344:600-15
Massey, Archna P; Harley, William R; Pasupuleti, NagaRekha et al. (2012) 2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator. Bioorg Med Chem Lett 22:2635-9
Sun, Yinghua; Hatami, Nisa; Yee, Matthew et al. (2010) Fluorescence lifetime imaging microscopy for brain tumor image-guided surgery. J Biomed Opt 15:056022
Harley, William; Floyd, Candace; Dunn, Tamara et al. (2010) Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain Res 1363:159-69
Zhao, Xueren; Gorin, Fredric A; Berman, Robert F et al. (2008) Differential hippocampal protection when blocking intracellular sodium and calcium entry during traumatic brain injury in rats. J Neurotrauma 25:1195-205
Schnier, Joachim B; Nishi, Kayoko; Harley, William R et al. (2008) An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas. J Neurooncol 89:19-26
Raichur, A; Vali, S; Gorin, F (2006) Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease. Neuroscience 142:859-70
Floyd, Candace L; Gorin, Fredric A; Lyeth, Bruce G (2005) Mechanical strain injury increases intracellular sodium and reverses Na+/Ca2+ exchange in cortical astrocytes. Glia 51:35-46

Showing the most recent 10 out of 14 publications